Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Neuropsychologia|August 3, 2024
Clinically established early Parkinson's disease patients do not show impaired use of priors in conditions of perceptual uncertaintyMatthieu Béreau, Axel Garnier-Allain, Mathieu Servant
Frontiers in Physiology|May 10, 2018
Could Sodium Chloride be an Environmental Trigger for Immune-Mediated Diseases? An Overview of the Experimental and Clinical EvidenceEric Toussirot, Matthieu Béreau, Charline Vauchy, et al.
Patient Preference and Adherence|May 4, 2013
Ustekinumab in chronic immune-mediated diseases: a review of long term safety and patient improvementEric Toussirot, Fabrice Michel, Matthieu Béreau, et al.
Neurological Research and Practice|December 16, 2020
Neurobiology and clinical features of impulse control failure in Parkinson's diseaseMatthieu Béreau, Paul Krack, Norbert Brüggemann, et al.
Biological Psychiatry|May 18, 2025
Is the medial subthalamic region in humans homologous to that in rodents? Relevance to neuropsychiatric disorders and their treatment with DBSMarie Barbier, Yvan Peterschmitt, Matthieu Béreau, et al.
Case Reports in Rheumatology|May 20, 2014
Occurrence of Psoriatic Arthritis during Interferon Beta 1a Treatment for Multiple SclerosisEric Toussirot, Matthieu Béreau, Marie Bossert, et al.
Revue Neurologique|September 19, 2018
Hyperdopaminergic behavioral spectrum in Parkinson's disease: A reviewMatthieu Béreau, Vanessa Fleury, Walid Bouthour, et al.
Soins; La Revue De Reference Infirmiere|March 7, 2024
[Parkinson's disease: intrinsically palliative care]Manon Auffret, Marc Vérin, Mathilde Giffard, et al.
Plos One|June 23, 2026
Revisiting the relationship between impulsivity, apathy, and action control: Bayesian inference from a stop-signal task studyEmma Michel, Axel Garnier-Allain, Mariia Kaliuzhna, et al.
Cells|June 28, 2023
Apathy in Parkinson's Disease: Clinical Patterns and Neurobiological BasisMatthieu Béreau, Vincent Van Waes, Mathieu Servant, et al.
Pageof 3